The company, which focuses on developing exoskeletons, plans to list on the NASDAQ under the symbol RWLK. Barclays and Jefferies acted as joint bookrunners on the deal, according to the report.
More articles on devices:
LifeScience Alley honors Zimmer’s Virage OCT Spinal Fusion System
5 key concepts on Zyga Technology’s $10M financing
Stryker looks to expand facility
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
